Editorial Policy

This policy explains how we create and maintain our educational content, how we evaluate evidence, how we handle conflicts of interest, and how we protect readers with clear safety and compliance standards.

Evidence hierarchy Independence & disclosures Corrections & updates

On this page

Purpose and scope

Red Yeast Rice Consumer Guide publishes educational information about red yeast rice (RYR) and related cholesterol-support supplements. We focus on clinical clarity: what the ingredient is, how it may work, what research suggests, what risks exist, and when medical supervision is prudent.

Medical disclaimer

Educational information only

Content on this website is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional for personalized guidance.

Core editorial principles

  • Accuracy over marketing: We prioritize evidence and safety signals over promotional claims.
  • Plain-language clinical tone: We translate research while keeping key caveats and uncertainties.
  • Safety-first framing: We highlight contraindications, interactions, and monitoring considerations.
  • Transparency: We disclose commercial relationships and explain how (and whether) they influence content.
  • Update discipline: We review pages and refresh content when authoritative guidance changes.

Why our tone is cautious

Some red yeast rice products may contain variable amounts of monacolins (including monacolin K, chemically identical to lovastatin), which can create statin-like benefits and statin-like risks. Product variability and contamination concerns (e.g., citrinin) are recurring quality issues in this category.

Editorial independence & conflict-of-interest standards

We maintain a separation between educational content and commercial activity. We do not accept payment to publish a predetermined conclusion about a supplement or product.

Affiliate and advertising disclosure

This website may receive compensation through affiliate relationships or advertising placements. If you click a link and make a purchase, we may earn a commission at no additional cost to you.

  • Compensation does not override our editorial standards.
  • We aim to present benefits, limitations, and safety considerations clearly.
  • When relevant, we describe what evidence is missing or uncertain.

What we do not do

  • We do not accept “pay-to-rank” product placements.
  • We do not sell user health data.
  • We do not publish undisclosed sponsored medical claims.

Evidence standards and source selection

We prioritize high-quality, primary and authoritative sources. When multiple sources disagree, we describe the uncertainty and avoid overstating conclusions.

Evidence hierarchy (general)

  • Highest weight: peer-reviewed systematic reviews, meta-analyses, and well-designed randomized trials
  • High weight: major health authority guidance and safety communications (e.g., NCCIH, FDA), and reputable medical institutions
  • Contextual weight: observational studies, mechanistic data, and pharmacology/safety literature
  • Lowest weight: marketing materials and non-reviewed claims (used only to describe what is being claimed)

How we treat supplement claims

We do not treat “natural,” “clinically proven,” or “doctor recommended” as evidence. We look for study design, outcomes, and whether the dose/form matches what is actually sold to consumers.

How we write different content types

Ingredient explainers

  • Define the ingredient and relevant active constituents (where applicable).
  • Explain plausible mechanisms without implying guaranteed outcomes.
  • Summarize evidence strength (what human data shows vs. what is unknown).
  • Highlight dose variability and quality issues when relevant.

Research reviews

  • Prefer peer-reviewed reviews and major authority guidance.
  • State limitations (population, duration, endpoints, confounding factors).
  • Separate cholesterol-marker changes from clinical outcomes (e.g., cardiovascular events) unless evidence supports the link.

Product or brand guides

  • Describe label claims and what consumers can verify.
  • Emphasize quality controls (third-party testing, contaminant screening) and transparency.
  • Do not claim to independently test every batch unless explicitly stated.

Medical review and fact-checking

We use a safety-first process: verify key pharmacology and safety points, confirm regulatory framing, and check that language remains compliant (educational, not treatment claims).

Our checks typically include

  • Confirming factual statements against primary or authoritative sources
  • Ensuring risks/interactions are described clearly and not minimized
  • Verifying that “studies show” statements reflect the study design and outcomes
  • Removing disease-treatment implications from supplement language

Updates, revisions, and corrections

We review and update pages when new high-quality evidence emerges, when a major health authority updates guidance, or when safety/regulatory information changes.

Corrections policy

  • If a factual error is confirmed, we correct it as quickly as practical.
  • We aim to preserve the meaning of the original content while making the correction clear.
  • For material changes, we update the “Last updated” date on the page.

How to request a correction

Send details via Contact Us. Please include the page URL, the specific statement, and a reliable source supporting the correction. Do not share personal medical details through web forms.

User privacy and data principles

  • We encourage readers not to submit sensitive personal health information via web forms.
  • We aim to keep disclosures and policies easy to find and understand.
  • For details, see our Privacy Policy and Terms of Service.
Transparency Safety-first Evidence-informed